Staff

Rare Brain Disorders Program Staff
Juan M. Pascual, M.D., Ph.D., is Principal Investigator for the Rare Brain Disorders Program. He holds The Once Upon a Time Foundation Professorship in Pediatric Neurologic Diseases and is a tenured faculty member (Associate Professor) in the Departments of Neurology and Neurotherapeutics, Physiology, and Pediatrics.
Levi Good, Ph.D, is an Instructor of Neurology and Neurotherapeutics. He is investigating the role in which brain metabolic dysfunction causes epilepsy.  Dr. Good also serves as the Scientific Director of the Department of Neurology and Neurotherapeutics' rodent EEG Core facility.  Dr. Good received his B.S. in Electrical Engineering with a Bioengineering Option from the University of Wyoming in 1999 before earning his Ph.D. in Biomedical Engineering at Arizona State University in 2007 with Dr. Leonidas Iasemidis.  He specializes in in vivo (EEG/ECoG) and in vitro (acute slice) electrophysiological testing with advanced signal processing methods (linear and nonlinear) in rodent models of epilepsy.  Currently, he is investigating the role of thalamocortical synchronization of brain activity as it pertains to seizure susceptibility, genesis, and treatment in a mouse model of Glut-1 deficiency.
Vikram Jakamsetti, M.D., Ph.D., is a postdoc investigating the neuronal consequences of pediatric energy metabolism disorders. He received his basic medical (MBBS) and Internal Medicine (MD) training in South Gujarat University (India). He then earned a Ph.D. in Cognition and Neuroscience with Dr. Michael Kilgard (UTD) while studying brain plasticity modulation by experience and pharmacology. He then explored plasticity in novel experience activated neurons with Dr. Kimberly Huber at UTSW. Dr. Jakamsetti has a deep interest in translational neuroscience and is currently investigating energy metabolism deficits known to occur in pediatric populations. His primary expertise is in neurophysiological techniques.

Dorothy Kelly, M.A., Senior Research Scientist, develops and oversees the clinical research for the Rare Brain Disorders Program. She received her B.A. in Psychology and M.A. in Experimental Psychology from Southern Methodist University. Ms. Kelly has more than ten years experience in clinical research, including work in bipolar disorder, ophthalmology, and pediatric neurocritical care. Currently, she is developing exploratory trials in pediatric metabolism deficit disorders.

Deborah Lewis, Senior Administrative Assistant, joined the Rare Brain Disorders Lab in  December, 2007. She supports the lab's research with multiple duties including oversight of supplies and equipment, payments and shipments of GLUT1 and other administrative tasks involving governmental and institutional policies. Deborah completed her BA in Business Administration in 1995.  She finds her work novel, important and exciting.
 
Qian Ma, M.D., Ph.D., Senior Research Scientist, received her medical degree from Lanzhou University School of Medicine, Lanzhou, China and a Ph.D. in medical science from Nagoya University School of Medicine, Nagoya, Japan. Qian joined the Pascual Lab in March 2007 as a research associate. Qian creates mouse models and studies the mechanism of rare brain disorders. The final goal of her studies is to develop new treatments for these disorders. Qian is in charge of the daily management of the lab, as well as animal breeding and colony maintenance.

Isaac Marin-Valencia, M.D., M.S., is a Postdoctoral Fellow and Chief Resident (2014-2015) in pediatric neurology. His research focuses on the cellular and molecular mechanisms of neurogenetic disorders in children, including structural and metabolic disorders, brain cancer and autism. His ultimate goal is the design of better diagnostic methods and therapies that can meaningfully impact children's wellbeing and intellectual development.
Publication in Cell Metabolism

Honors and Awards:
Postdoc symposium honors excellence in research mentoring

Research Poster Grand prize
Fred Baskin Research Award
Chief Resident, Pediatric Neurology

Karthik Rajasekaran, Ph.D. is an Instructor of Neurology and Neurotherapeutics. Dr. Rajasekaran's research focuses on the study of synaptic plasticity in epilepsy to understand the pathophysiology of benzodiazepine-refractory status epilepticus, secondarily acquired temporal lobe epilepsy, and genetically determined epileptic encephalopathies.
Charles R. Roe, M.D., is a Volunteer Faculty member with the Department of Neurology and Neurotherapeutics. He received his M.D. in 1964 from Duke University Medical Center, where he also completed his residency in pediatrics and a fellowship in metabolic disease. He received two years of additional training in the department of biochemistry at Brandeis University. During his fellowship training he developed the creatine kinase MB isoenzyme test for the recognition of acute heart attacks, which became a gold standard for diagnosis worldwide. He served as professor of pediatrics and the chief of the division of genetics and metabolism at Duke Medical Center from 1975 to 1995 before assuming the directorship of the Kimberly H. Courtwright and Joseph W. Summers Institute of Metabolic Disease, from which he moved to UT Southwestern. Dr. Roe has authored more than 300 publications in the field of pediatrics and inherited metabolic disease and has characterized four new inherited diseases during his career. He has also developed a world-renowned supplemental newborn screening program which tests infants for more than 30 inherited metabolic diseases not detected by routine state newborn screening.
Cary Trent Cary Trent, B.S., is a Research Technician II who works with experimental models for Glut-1 Deficiency.  She received her B.S. in Animal Science from California Polytechnic State University in 2007.  Currently, she is conducting a behavioral epilepsy study.  Previously, Cary worked in pediatric neurology research at UT Southwestern.